Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | AMRX Amneal Pharmaceuticals, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $19.50 +4.2% | $15.87 +5.4% |
| StockIQ Score | 68B- Moderate Risk: Medium | 36F Weak Risk: High |
| Technical | 90A+ | 16F |
| Fundamental | 52C- | 35F |
| Growth | 73B | 50C- |
| Fair Value | 33F | 38F |
| News | 100A+ | 50C- |
| Quality | 63C+ | 50C- |
| Risk | 62C+ | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Amneal Pharmaceuticals (AMRX) outperforms Ascentage Pharma (AAPG) in nearly every category. AMRX has a stronger investor score (54 vs. 37) and a higher overall rating (Moderate vs. Weak). Its growth score (73) and fundamental score (52) are significantly better than AAPG’s (50 and 35, respectively), though AAPG’s valuation score (38) is slightly higher than AMRX’s (33). AMRX also leads in technicals (44 vs. 18).
